3
Participants
Start Date
January 25, 2022
Primary Completion Date
April 25, 2027
Study Completion Date
April 25, 2027
Carboplatin
Given IV
Endoscopic Biopsy
Undergo endoscopic biopsy
External Beam Radiation Therapy
Undergo EBRT
Lenvatinib Mesylate
Given PO
Paclitaxel
Given IV
Pembrolizumab
Given IV
Resection
Undergo surgical resection
City of Hope Medical Center, Duarte
National Cancer Institute (NCI)
NIH
City of Hope Medical Center
OTHER